Antibe Therapeutics Inc (ATBPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,021 | -8,045 | -4,304 | -14,594 | -11,837 |
| Income taxes - deferred | N/A | N/A | N/A | 197 | 192 |
| Accounts receivable | -13 | -56 | 50 | N/A | 407 |
| Other Working Capital | -464 | -417 | 585 | -511 | 225 |
| Other Operating Activity | 585 | 307 | 260 | 2,573 | 1,487 |
| Operating Cash Flow | $-10,914 | $-8,210 | $-3,410 | $-12,335 | $-9,527 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,857 | -10,003 | -7,519 | -36,642 | -28,110 |
| PPE Investments | N/A | N/A | N/A | -7 | -8 |
| Net Acquisitions | 643 | N/A | N/A | 241 | 412 |
| Other Investing Activity | 23,495 | 16,267 | 12,445 | 27,460 | 19,390 |
| Investing Cash Flow | $14,280 | $6,264 | $4,925 | $-8,947 | $-8,315 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | -1 |
| Debt Repayment | N/A | N/A | N/A | 120 | N/A |
| Other Financing Activity | 0 | 0 | 0 | -60 | -58 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $61 | $-58 |
| Beginning Cash Position | 4,961 | 5,035 | 5,024 | 26,332 | 25,663 |
| End Cash Position | 8,327 | 3,088 | 6,540 | 5,110 | 7,763 |
| Net Cash Flow | $3,367 | $-1,947 | $1,516 | $-21,221 | $-17,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,914 | -8,210 | -3,410 | -12,335 | -9,527 |
| Capital Expenditure | N/A | N/A | N/A | -7 | -8 |
| Free Cash Flow | -10,914 | -8,210 | -3,410 | -12,342 | -9,535 |